Metabolic and vascular safety of the combination 17β-estradiol and chlormadinone acetate in normal or at arterial risk postmenopausal women: A prospective, controlled, randomized, long term (18 months) study;Tolerance clinique, metabolique et vasculaire de l'association 17β- estradiol et acetate de chlormadinone chez la femme menopausee normale ou a risque arteriel - Etude prospective, controlee, randomisee, a long terme (18 mois)

Revue du Praticien - Gynecologie et Obstetrique

Volumn , Issue 29, 1999, Pages 29-34

  Pélissier, Clara ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Estradiol and chlormadinone acetate; Menopausal hormonal replacement therapy; Metabolic and vascular safety; Postmenopausal women with arterial risk; Randomized long term study

Indexed keywords

CHLORMADINONE ACETATE; CHOLESTEROL; ESTRADIOL; ESTROGEN; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSLIPIDEMIA; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

EID: 0033051913     PISSN: 12801437     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Grodstein F, Stampfer MJ, Colditz GA et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997 ; 336 : 1769-75.
2. Grady D, Susan MR, Diana BP et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992 ; 117 : 1016-37.
3. Glusa E, Grader T, Wagner S, Œttel M. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 1997 ; 28 : 181-91.
4. Collins P, Rosano GMC, Sarrel PM et al. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation Shock 1995 ; 92 : 24-30.
5. Skafar DF, Xu R, Morales J, Ram J, Sowers JR. Female sex hormones and cardiovascular disease in women. J Clin Endocrinol Metab 1997 ; 82 : 3913-8.
6. Rosano GM, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effects of estrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993 ; 342 : 133-6.
7. Rosano GM, Peters NS, Lefroy D et al. 17β-estradiol therapy lessers angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996 ; 28 : 1500-5.
8. Albertsson PA, Emanuelsson H, Milsom I. Beneficial effects of treatment with transdermal estradiol-17β on exercise-induced angina and ST-segment depression in syndrome X. Int J Cardiol 1996 ; 54 : 13-20.
9. Plushner SL. Lipoprotein disorders in women: which women are the best candidates for hormone replacement therapy? Ann Pharm 1997 ; 31 : 98-107.
10. Grodstein F, Stampfer MJ, Manson JE et al. Postmenopausal estroen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996 ; 15 : 453-61.
11. Pélissier C. Caby J. Contraception des femmes à haut risque vasculaire et métabolique. Essai d'un dérivé de la 17 OH-progestérone. Gynecologie 1983 : 34 : 131-8.
12. Pélissier C, Basdevant A, Egloff M, Hussun T, Guyenne TT. Contraception progestative par l'acétate de chlormadinone chez des femmes à risque vasculaire. Contraeept Fertil Sex 1987 ; 15 : 45-54.
13. Pélissier C, Basdevant A, Conard J et al. Administration prolongée d'acétate de chlormadinone. Effets métaboliques, tensionnels et hormonaux. Gynécologie 1991 ; 42 : 79-86.
14. Pélissier C, Maroni M, Yaneva H, Brin S, Jondet M. Chlormadinone acetate (CA) to micronized progestrone (MP) in the sequential hormonal replacement therapy. Maturitas 1997(abstr. F104) : 27 (suppl.) : 74.
15. Jondet M, Pelissier C. Maroni M, Peltier-Pujol F, Yaneva H. Histological comparison of chlormadinone acetate (CA) and micronized progesterone (MP) in menopausal sequential hormonal therapy (HRT). IInd Congress of the European Society of Gynaecology, October 30-November 1, 1997.
16. Chabert-Buffet N, Blétry O, Clauvel JP et al. Pregnane progestin is a safe contraception in patients with systemic lupus erythematosus (SLE). Arthritis Rheumat 1997 (abstr. 1763) ; 40 (suppl. 9) : S325.
17. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors Ln postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995 ; 273 : 199-208.
18. Barret-Connor E, Slone S, Greendale G et al. The postmenopausal estrogen/progestin interventions study: primary outcomes in adherent women. Maturitas 1997 ; 27 : 261-74.
19. Jensen J, Riis BJ, Strom V, Nilas L, Christiansen C. Long term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal women. Am J Obstet Gynecol 1987 ; 156 : 66-7.
20. Voetberg GA, Netelenhos JC, Kenemans P, Petters-Muller ER, Van de Weijer PH. Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone: effects on calcium and lipid metabolism. J Clin Endocrinol Metab 1994 ; 79 : 1465-9.
21. Tonstad S, Ose L, Gorbitz C, Djoseland O, Bard JM. Fruchart JC. Efficacy of sequential hormone replacement therapy in the treatment of hypercholesterolemia among postmenopausal women. J Int Med 1995 ; 238 : 39-47.
22. Bissonette F, Lussier-Cacan S, Fiigère P. Bérubé S. Metabolic effect of two hormonal preparations in postmenopausal women. Maturitas 1997 ; 27 : 275-84.
23. Jamin C, Zatarian M, Colau JC. Le nomégestrol acétate n'altère pas les modifications des lipides, lipoproteines, apoprotéines. Lp(a), LpA-I et homocystéine induites par une œstrogénothérapie à long terme. Gynecol Obstet 1996 ; 4 : 273-8.
24. Conard J, Basdevant A, Thomas JL et at. Cardiovascular risk factors and combined estrogen-progestin replacement therapy : a placebo-controlled study with nomegestrol acetate and estradiol. Fertil Steril 1995 ; 64 : 957-62.
25. Denke MA. Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women. Am J Med 1995 ; 99(1) : 29-35.